Hikma Pharmaceuti…
GBGBPHikma Pharmaceuticals PLC (LSE:HIK) — Drug Manufacturers - Specialty & Generic. Število borz, na katerih se trgujejo delnice družbe: 2. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
O Podjetju
- Spletna Stran
- hikma.com
- Sektor
- Healthcare · Drug Manufacturers - Specialty & Generic
- Sedež
- London, United Kingdom
- Izvršni Direktor
- Said Darwazah
- Zaposleni
- 9 500
- Ustanovljena
- 1978
- Na Borzi od
- 01.11.2005 (LSE:HIK)
- Delnice v Obtoku
- 206.97 mio.
- Prosto Prenosljive Delnice
- 146.44 mio.
- Tržna Kapitalizacija
- 3.27 mrd. GBP
- Notranje Osebe
- 32.39%
- Institucionalni Vlagatelji
- 40.34%
- ISIN
- GB00B0LCW083
- LEI
- 549300BNS685UXH4JI75
Opis
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.
Dividende
Hikma Pharmaceuticals PLC (HIK) izplačuje dividende dvakrat letno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 0.6438 GBP na delnico (plačila: 2). To je približno 3.98% trenutne cene delnice. Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 07.01.2027.
| Ex-Datum | Izplačilo | Znesek | % | Vrsta | Oznaka |
|---|---|---|---|---|---|
| 2026-08-13 | 2026-09-17 | 0.2909 GBP | 1.8/3.9 % | polletno | LSE:HIK |
| 2026-03-19 | 2026-04-30 | 0.3529 GBP | 2.7/4.9 % | polletno | LSE:HIK |
| 2025-08-14 | — | 0.2728 GBP | 1.5/3.6 % | polletno | LSE:HIK |
| 2025-03-20 | 2025-05-01 | 0.3721 GBP | 1.8/3.0 % | polletno | LSE:HIK |
| 2024-08-15 | — | 0.2426 GBP | 1.2/2.9 % | polletno | LSE:HIK |
| 2024-03-21 | — | 0.3714 GBP | 1.9/2.9 % | polletno | LSE:HIK |
| 2023-08-10 | — | 0.1988 GBP | 0.9/2.2 % | polletno | LSE:HIK |
| 2023-03-23 | — | 0.2952 GBP | 1.7/2.7 % | polletno | LSE:HIK |
| 2022-08-18 | — | 0.1600 GBP | 1.1/2.8 % | polletno | LSE:HIK |
| 2022-03-17 | — | 0.2600 GBP | 1.3/1.3 % | polletno | LSE:HIK |
Največji Imetniki
| Imetnik | Delež | Delnice | Datum Poročila |
|---|---|---|---|
| Darhold Ltd | ≈28.74% | 60 mio. | 2025-02-25 |
| Hikma Pharmaceuticals PL… | ≈6.15% | 12.83 mio. | 2026-08-18 |
| Vanguard Group Inc. | ≈4.94% | 10.31 mio. | 2026-07-22 |
| BlackRock Inc. | ≈4.79% | 10 mio. | 2025-02-25 |
| Boston Partners Internat… | ≈1.7% | 3.55 mio. | 2026-08-12 |
| HARTFORD MUTUAL FUNDS IN… | 1.37% | 2.86 mio. | 2026-07-31 |
| VANGUARD SPECIALIZED FUN… | 1.23% | 2.57 mio. | 2026-07-31 |
| VANGUARD STAR FUNDS-Vang… | 1.04% | 2.17 mio. | 2026-07-31 |
| Darwazeh (Mazen Samih Ta… | ≈1.04% | 2.17 mio. | 2026-06-01 |
| John Hancock Investment… | 0.95% | 1.98 mio. | 2026-07-31 |
| Darwazah (Said Samih Tal… | ≈0.74% | 1.54 mio. | 2026-06-01 |
| Hikma Pharmaceuticals Em… | ≈0.7% | 1.46 mio. | 2024-12-31 |
| VANGUARD TAX-MANAGED FUN… | 0.69% | 1.44 mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 0.58% | 1.21 mio. | 2026-08-31 |
| Al-Husry (Ali) | ≈0.56% | 1.16 mio. | 2024-12-31 |
| Kanaan (Bassam Wael Rosh… | ≈0.37% | 762 210 | 2026-06-01 |
| College Retirement Equit… | 0.33% | 682 476 | 2026-06-30 |
| DFA INVESTMENT TRUST CO-… | 0.32% | 660 101 | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.27% | 559 402 | 2026-07-31 |
| John Hancock Varbl Insur… | 0.26% | 535 851 | 2026-06-30 |
| Paradigm Asset Managemen… | 0% | 955 | 2023-09-30 |
